BioSpace News Archive

BioMidwest

Zynex Announces Additional Share Buyback Program - November 01, 2022

Zynex, Inc. announced that its board of directors approved a program to buy back $10.0 million of the Company’s common stock.

November 1, 2022
·
4 min read
Biotech Beach

ATEC to Participate in Upcoming Investor Conferences - November 01, 2022

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that management will participate in the following investor events.

November 1, 2022
·
1 min read
Drug Development

Pieris Pharmaceuticals Announces Dosing of First Subject in Phase 1 Trial of Inhaled CTGF Inhibitor PRS-220

Pieris Pharmaceuticals, Inc. announced that the first subject has been dosed in the phase 1 study of PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis and other forms of fibrotic lung disease.

November 1, 2022
·
4 min read
Lexaria Receives Independent Review Board Approval for its Upcoming Human Oral Nicotine Study

Lexaria Bioscience Corp., a global innovator in drug delivery platforms is pleased to announce that independent review board approval has now been received for human clinical nicotine study NIC-H22-1, and that human dosing will begin soon.

November 1, 2022
·
6 min read
Bio NC

Merz Aesthetics® Announces Teyana Taylor as New Xeomin® (incobotulinumtoxinA) Brand Partner

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced Teyana Taylor as the latest Xeomin® (incobotulinumtoxinA) brand partner.

November 1, 2022
·
9 min read
Biological Data Visualization Market Size Will Attain USD 2.3 BN by 2030

The Global Biological Data Visualization Market Size accounted for USD 589.7 million in 2021 and is estimated to achieve a market size of USD 2.3 Billion by 2030 growing at a CAGR of xx% from 2022 to 2030.

November 1, 2022
·
12 min read
Biotech Beach

MedCrypt Raises $25M Series B for Continued Growth and Innovation in Medical Device Cybersecurity

MedCrypt, Inc., the proactive cybersecurity solution provider for medical devices, today announced its $25M Series B funding round.

November 1, 2022
·
3 min read
FDA

FDA approves Cochlear’s Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor.

November 1, 2022
·
7 min read
Lone Star Bio

Natera to Participate in Credit Suisse 31st Annual Healthcare Conference

Natera, Inc.today announced that Steve Chapman, chief executive officer, and Mike Brophy chief financial officer, will be presenting at the Credit Suisse 31st Annual Healthcare Conference on Wednesday, November 9 at 10:25 a.m. PT ( 1:25 p.m. ET ).

November 1, 2022
·
1 min read
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™, a New and Innovative Ready-To-Use Vial Platform

Stevanato Group S.p.A. and Gerresheimer AG announced at CPhl Worldwide the official launch of a new and innovative ready-to-use vial platform, EZ-fill Smart™, a solution designed to improve drug packaging quality, reduce total cost of ownership, and shorten lead times for customers.

November 1, 2022
·
7 min read